iBio Inc (IBIO)’s Market Momentum: Closing Strong at 1.96, Up 0.52

Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, iBio Inc’s stock clocked out at $1.96, up 0.52% from its previous closing price of $1.95. In other words, the price has increased by $0.52 from its previous closing price. On the day, 66458.0 shares were traded. IBIO stock price reached its highest trading level at $2.03 during the session, while it also had its lowest trading level at $1.9.

Ratios:

To gain a deeper understanding of IBIO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.69 and its Current Ratio is at 1.69. In the meantime, Its Debt-to-Equity ratio is 0.70 whereas as Long-Term Debt/Eq ratio is at 0.15.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Chardan Capital Markets on May 28, 2024, initiated with a Buy rating and assigned the stock a target price of $5.

On November 29, 2021, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $1.50.

On January 22, 2021, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $3.Cantor Fitzgerald initiated its Overweight rating on January 22, 2021, with a $3 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 01 ’23 when Brenner Martin sold 4,881 shares for $0.27 per share. The transaction valued at 1,296 led to the insider holds 182,502 shares of the business.

Brenner Martin sold 5,267 shares of IBIO for $1,592 on Oct 03 ’23. The insider now owns 187,383 shares after completing the transaction at $0.30 per share. On Oct 02 ’23, another insider, Brenner Martin, who serves as the insider of the company, sold 4,215 shares for $0.31 each. As a result, the insider received 1,311 and left with 192,650 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IBIO now has a Market Capitalization of 16988650 and an Enterprise Value of 29643642. For the stock, the TTM Price-to-Sale (P/S) ratio is 337.92 while its Price-to-Book (P/B) ratio in mrq is 0.67. Its current Enterprise Value per Revenue stands at 592.873 whereas that against EBITDA is -1.719.

Stock Price History:

The Beta on a monthly basis for IBIO is -3.36, which has changed by -0.83305085 over the last 52 weeks, in comparison to a change of 0.25510752 over the same period for the S&P500. Over the past 52 weeks, IBIO has reached a high of $15.99, while it has fallen to a 52-week low of $1.02. The 50-Day Moving Average of the stock is -7.49%, while the 200-Day Moving Average is calculated to be -30.04%.

Shares Statistics:

It appears that IBIO traded 263.67K shares on average per day over the past three months and 88170 shares per day over the past ten days. A total of 8.62M shares are outstanding, with a floating share count of 8.61M. Insiders hold about 0.16% of the company’s shares, while institutions hold 35.29% stake in the company. Shares short for IBIO as of 1718323200 were 134256 with a Short Ratio of 0.51, compared to 1715731200 on 80567. Therefore, it implies a Short% of Shares Outstanding of 134256 and a Short% of Float of 1.5599999999999998.

Earnings Estimates

On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$41. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.

Analysts are recommending an EPS of between -$10.61 and -$10.61 for the fiscal current year, implying an average EPS of -$10.61. EPS for the following year is -$1.53, with 1.0 analysts recommending between -$1.53 and -$1.53.

Most Popular